ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasani, A
Right arrow Articles by Chung, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasani, A
Right arrow Articles by Chung, K.
Eur Respir J 1994; 7: 1497-1500
Copyright © ERS Journals Ltd 1994


Clinical Trial

Inhaled frusemide does not affect lung mucociliary clearance in healthy and asthmatic subjects

A Hasani, D Pavia, MA Spiteri, CT Yeo, JE Agnew, SW Clarke, and KF Chung

Inhaled frusemide has been shown to protect against the bronchoconstrictor effect of several inhaled agents in asthmatic subjects by mechanism(s) that are unclear. Since loop diuretics can modulate Cl- transport in the airway epithelium, frusemide may alter the quality and/or the quantity of the periciliary layer, which in turn may affect lung mucociliary transport. We investigated the effect of a single inhalation of nebulized frusemide (40 mg) on lung mucociliary clearance in four healthy subjects and in seven stable, mild asthmatics using an objective radioaerosol technique. Frusemide or placebo was inhaled in a double-blind, randomized, cross-over manner half an hour after the inhalation of 5 microns polystyrene particles labelled with 99mTc, used for assessing mucociliary clearance. The pulmonary function and initial radioaerosol distribution were similar between frusemide and placebo runs within each of the two study groups. The areas under the tracheobronchial retention curves over the 6 h observation period were similar between frusemide and placebo runs for both groups. Our findings show inhaled frusemide, at a dose known to inhibit bronchoconstrictor responses, does not affect lung mucociliary clearance.


This article has been cited by other articles:


Home page
Chronic Respiratory DiseaseHome page
A Hasani, T. Chapman, D McCool, R. Smith, J. Dilworth, and J. Agnew
Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis
Chronic Respiratory Disease, May 1, 2008; 5(2): 81 - 86.
[Abstract] [PDF]


Home page
ChestHome page
A. Hasani, N. Toms, J. E. Agnew, M. Sarno, A. J. Harrison, and P. Dilworth
The Effect of Inhaled Tiotropium Bromide on Lung Mucociliary Clearance in Patients With COPD
Chest, May 1, 2004; 125(5): 1726 - 1734.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. S. Niven and G. Argyros
Alternate Treatments in Asthma
Chest, April 1, 2003; 123(4): 1254 - 1265.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. L. Winters and D. B. Yeates
Interaction between ion transporters and the mucociliary transport system in dog and baboon
J Appl Physiol, October 1, 1997; 83(4): 1348 - 1359.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the European Respiratory Society.